In September, Turkey began trials with 13,000 volunteers on a two-dose 14-day interval.
It purchased 4 million doses from Turkey and 5 million doses from China.
The analysis was based on the intervention modified intention-to-treat cohort.
In August, a trial was started in Chile run by which was expected to include 3,000 volunteers between the ages of 18 and 65.